Liwen Chen
678 Furong Road
Hefei, China
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
MiR-29a/DNMT3A axis participates in Dihydroartemisinin's suppression on lung adenocarcinoma: Implications for overcoming acquired resistance to EGFR-TKIs.
Journal: Toxicology and applied pharmacology
Published: January 11, 2026
Dihydroartemisinin inhibits NSCLC by targeting MDM2/c-Myc axis independent of p53.
Journal: Biochemical pharmacology
Published: April 21, 2025
Connection between circulating inflammatory cytokines and non-small cell lung cancer: integrated Mendelian randomization and gene function analysis.
Journal: Discover oncology
Published: November 22, 2024
Screening and validation of plasma cell-derived, purinergic, and calcium signalling-related genetic signature to predict prognosis and PD-L1/PD-1 blockade responses in lung adenocarcinoma.
Journal: Journal of cancer research and clinical oncology
Published: May 26, 2023
Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer.
Journal: Journal of cancer research and clinical oncology
Published: March 21, 2023
Characteristics of immunological events in Epstein-Barr virus infection in children with infectious mononucleosis.
Journal: Frontiers in pediatrics
Published: October 02, 2022
Endoplasmic Reticulum Aminopeptidase 1 Is Involved in Anti-viral Immune Response of Hepatitis B Virus by Trimming Hepatitis B Core Antigen to Generate 9-Mers Peptides.
Journal: Frontiers in microbiology
Published: December 05, 2021
B7-H3 is eligible for predicting clinical outcomes in lung adenocarcinoma patients treated with EGFR tyrosine kinase inhibitors.
Journal: World journal of surgical oncology
Published: December 01, 2021
Hepcidin expression levels involve efficacy of pegylated interferon-α treatment in hepatitis B-infected liver.
Journal: International immunopharmacology
Published: October 15, 2021
Total serum bile acids predict therapy for HBeAg-negative chronic hepatitis B patients with borderline ALT and high HBV DNA.
Journal: Journal of infection in developing countries
Published: October 10, 2021
B7‑H3 promotes the epithelial‑mesenchymal transition of NSCLC by targeting SIRT1 through the PI3K/AKT pathway.
Journal: Molecular medicine reports
Published: September 30, 2021
Last Updated: 09/26/2026